News
We are happy to share the news that Dr. Christoph Kausch, our Managing Partner at MTIP, made the list for Real Deals most influential for 2022.
We are happy to share the news that Dr. Christoph Kausch, our Managing Partner at MTIP, made the list for Real Deals most influential for 2022.
Real Deals has compiled a list of the most influential individuals, firms and movements that have defined, innovated and transformed private equity over the last twelve months.
We are happy to share the news that Dr. Christoph Kausch, our Managing Partner at MTIP, made the list for Real Deals most influential for 2022. Real Deals publishes the most important European private equity news, alongside deep analysis and comprehensive deal coverage.
MTIP marks its place on this year’s list for being one of the first investors active in the healthtech space. Founding member of the Swiss-based growth equity healthtech investor, Dr. Christoph Kausch, has been instrumental in tailoring the firm’s investment thesis, backing digital health and digitally connected medical device companies. MTIP also takes an active role in ESG, with its second fund achieving “dark green” status as an Article 9 fund within SFDR. The practicalities of achieving Article 9 status have really come to light in 2022, with many of the latest PE fundraisings only able to get as high as Article 8. The status was achieved for MTIP’s contribution to tackling “inequality in access to quality healthcare for disadvantaged communities”. The GP also has a significant focus on social responsibility.
“Our mission at MTIP is to build the healthtech leaders of tomorrow,” said Dr. Christoph Kausch, Managing Partner at MTIP. “The trust our investors have put in us is a great endorsement of our strategy that’s built on our sector focus and proven approach to value creation. Being listed as one of Real Deals most influential individuals of 2022 is a phenomenal recognition for the achievements we secured in the last 12 months.”
About MTIP
MTIP is a leading Swiss-based growth equity firm investing in European healthtech companies. We leverage our deep sector expertise to help the founders scale up successful and sustainable digital health businesses. At MTIP, we are driven by the mission to empower healthtech innovation with the potential to impact and improve millions of lives.
.svg)
.svg)
